Major depressive disorder

Surgical Versus Low-Dose Progestin Treatment for Endometriosis-Associated Severe Deep Dyspareunia II: Effect on Sexual Functioning, Psychological Status and Health-Related Quality of Life.

Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: Effect on sexual functioning, psychological status and health-related quality of life.

Hum Reprod. 2013 Feb 26;
Vercellini P, Frattaruolo MP, Somigliana E, Jones GL, Consonni D, Alberico D,… Continue reading →

Gene-Environment Interactions in Major Depressive Disorder.

Gene-environment interactions in major depressive disorder.

Can J Psychiatry. 2013 Feb; 58(2): 76-83
Klengel T, Binder EB

Family, twin, and epidemiologic studies have suggested that both genes and environment are important risk factors for the development of major depressive… Continue reading →

[Remission, Response, and Its Prediction in Depressive Inpatients.]

[Remission, Response, and its Prediction in Depressive Inpatients.]

Psychother Psychosom Med Psychol. 2013 Feb 26;
Harbeck S, Kliem S, Wollburg E, Braukhaus C, Kröger C

Using mean comparisons and effect sizes to report effects of inpatient treatment, this not… Continue reading →

Acute Psychological Stress Results in the Rapid Development of Insulin Resistance.

Acute Psychological Stress Results in the Rapid Development of Insulin Resistance.

J Endocrinol. 2013 Feb 26;
Li L, Li X, Zhou W, Messina J

In recent years, the roles of chronic stress and depression as an independent risk factor… Continue reading →

Using the High-Risk Family Design to Identify Biomarkers for Major Depression.

Using the high-risk family design to identify biomarkers for major depression.

Philos Trans R Soc Lond B Biol Sci. 2013; 368(1615): 20120129
Talati A, Weissman MM, Hamilton SP

The familial nature of major depressive disorder (MDD) is now well… Continue reading →

Anxiety and Affective Disorder Comorbidity Related to Serotonin and Other Neurotransmitter Systems: Obsessive-Compulsive Disorder as an Example of Overlapping Clinical and Genetic Heterogeneity.

Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.

Philos Trans R Soc Lond B Biol Sci. 2013; 368(1615): 20120435
Murphy DL, Moya PR, Fox… Continue reading →

The Serotonergic System in Mood Disorders and Suicidal Behaviour.

The serotonergic system in mood disorders and suicidal behaviour.

Philos Trans R Soc Lond B Biol Sci. 2013; 368(1615): 20120537
Mann JJ

A stress-diathesis explanatory model of suicidal behaviour has proved to be of heuristic value, and both clinical… Continue reading →

Validation of a Dutch Version of the Neurological Fatigue Index (NFI-MS) for Patients With Multiple Sclerosis in the Netherlands.

Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands.

Qual Life Res. 2013 Feb 26;
Derksen A, Mokkink LB, Rietberg MB, Knol DL, Ostelo RW, Uitdehaag BM

PURPOSE: Fatigue… Continue reading →

Imaging Dopamine Transmission in the Frontal Cortex: A Simultaneous Microdialysis and [(11)C]FLB 457 PET Study.

Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [(11)C]FLB 457 PET study.

Mol Psychiatry. 2013 Feb 26;
Narendran R, Jedema HP, Lopresti BJ, Mason NS, Gurnsey K, Ruszkiewicz J, Chen CM, Deuitch L, Frankle WG, Bradberry… Continue reading →